Hamptons Homebuildi...
Health Care: Drugs
Dendreon Corp (DNDN: NASDAQ)
$3.89 -0.02 | -0.51%
05/24/13 - 04:00 PM ET
2.06M / 4.53M
Vol / Avg. Vol:3.92 / 3.91
Open / Prev. Close:3.86 - 3.93
Today's Range:3.69 - 7.94
52 Wk Range:-25.33%
Performance YTD:TheStreet Rating:
Portfolios with DNDN
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorMost-Active Stocks for the ...
- Usersuresh45
- ContributorStocks Under-$10 Moving Hig...
- Usercarver
- UserZeca
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserLong Term Stock Picks
Latest DNDN Headlines from TheStreet
- Oversold Conditions For Dendreon (DNDN) 04.18.13 | 04:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Cramer's 'Mad Money' Recap: It's Time to Pause 03.21.13 | 08:03 pm
- Shocker! Sell-Sider Admits Dendreon Buy Rating Was Mistake 03.06.13 | 10:03 am
- Why Expect More Price Swings From These 4 Biotechs 02.28.13 | 11:02 am
- Dendreon Corp (DNDN): Today's Featured Drugs Winner 01.28.13 | 05:01 pm
- Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocks 01.28.13 | 06:01 am
- Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharma 01.18.13 | 08:01 am
- Cramer's 6 Stocks in 60 Seconds: CMI CVX PG BUD PRGO DNDN 01.11.13 | 10:01 am
- Arena Pharmaceuticals And 6 More Stocks To Watch 01.07.13 | 07:01 pm
Press Releases for DNDN
- Dendreon Announces Securities Class Action Settlement - Business Wire 03.18.13 | 08:03 am
- Dendreon Announces Webcast Presentation At ROTH Conference - Business Wire 03.12.13 | 07:03 pm
- Dendreon Announces Fourth Quarter And 2012 Year End Results - Business Wire 02.25.13 | 07:02 am
- New PROVENGE® (sipuleucel-T) Data To Be Presented At 2013 American Society Of Clinical Oncology (ASCO) Genitourinary Cancers Symposium - Business Wire 02.13.13 | 08:02 am
- Dendreon To Host Conference Call On February 25 To Announce Fourth Quarter And Full Year 2012 Financial Results And Webcast Presentations At Upcoming Conferences - Business Wire 01.30.13 | 08:01 am
- Dendreon Announces Preliminary Fourth Quarter 2012 Revenues - Business Wire 01.07.13 | 09:01 am
- Dendreon Sells New Jersey Immunotherapy Manufacturing Facility - Business Wire 12.20.12 | 08:12 am
- Dendreon Announces Webcast Presentations At Upcoming Conferences - Business Wire 11.27.12 | 06:11 pm
- Dendreon Appoints Lindsay Rocco To Lead Corporate Communications - Business Wire 11.14.12 | 08:11 am
- Dendreon Announces Third Quarter 2012 Results - Business Wire 11.02.12 | 08:11 am
Partner Headlines for DNDN
- After Hours Most Active for Apr 19, 2013 : PBR/A, CRM, PPL, DOW, GILD, MS, QQQ, EMC, DTV, DNDN, SQNM, YHOO - NASDAQ 04.19.13 | 08:04 pm
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- 6 Reasons To Buy Dendreon Right Now - Seeking Alpha 03.09.13 | 08:03 am
- Today's Market News To Trade On: 5 Stocks Moving On News - Seeking Alpha 02.11.13 | 09:02 am
- Stock Watch Tuesday, 8 January - Seeking Alpha 01.08.13 | 09:01 am
- Stock Watch Thursday, 20 December - Seeking Alpha 12.20.12 | 09:12 am
- Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned - Seeking Alpha 12.16.12 | 08:12 am
- Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) - Benzinga 11.12.12 | 01:11 pm
- The January Effect And 3 Biopharma Stocks - Seeking Alpha 11.09.12 | 09:11 am
- Mid-Afternoon Market Update: Markets Remain Down - Benzinga 11.02.12 | 03:11 pm
